TissueScan, Cancer Survey cDNA Array 96 - I

Snippet: The expression of SIX1 was assessed by RT-qPCR in commercial TissueScan qPCR Cancer Survey cDNA arrays I (Origene, #CSRT101)

Snippet: Analyses of SIX1 Expression in Human Cancer Samples The expression of SIX1 was assessed by RT-qPCR in commercial TissueScan qPCR Cancer Survey cDNA arrays I (Origene, #CSRT101). The array consists of 72 tumors and 24 non-malignant tissue samples

Snippet: … The BTG/Tob proteins are structurally characterized by the highly conserved N-terminal BTG domain, which contains two conserved motifs, BOX-A and BOX-B, whereas their C-terminal reg;- Figure 7. The expression of BTG4 mRNA in lung and colon cancers. BTG4 expression levels in normal and cancerous tissues were analyzed with quantitative RT-PCR using OriGene TissueScan cancer panels (CSRT101). 0 denotes normal lung or colorectal tissues

Snippet: Table S1). We then checked the expression levels of h4g using the human cancer survey cDNA panel (ORIGENE) contain- ing eight different tumors (breast, colon, kidney, liver, lung, ovary, prostate and thyroid). The results

Snippet: in patient samples with metastatic breast tumors [5–7]. However, to date, there has been no direct in vivo examination of the role of specific SHC1 protein isoforms in the progression of mammary tumorigenesis. The ubiquitously expressed adaptor protein SHC1 [8] exists in three isoforms with relative molecular masses of 46 kDa, 52 kDa, and 66 kDa (p46SHC, p52SHC, and p66SHC) encoded by sin